Skip to main content
WooGeneB&GCO.,Ltd logo

WooGeneB&GCO.,Ltd — Investor Relations & Filings

Ticker · 018620 ISIN · KR7018620005 KO Manufacturing
Open in API
Filings indexed 238 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 018620

About WooGeneB&GCO.,Ltd

http://www.woogenebng.com

WooGene B&G Co., Ltd. is a company specializing in animal health. It engages in the research, development, manufacturing, and marketing of a comprehensive range of veterinary medicines, vaccines, and feed supplements. The product portfolio includes pharmaceuticals such as anti-infectives, antibiotics, and pesticides, designed for livestock including swine, poultry, and cattle, as well as for aquatic species. The company utilizes biotechnology and microbial technology to develop innovative solutions that promote animal health and productivity. It also manufactures raw materials for medicines, serving both domestic and international markets.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 96% confidence The document is clearly labeled as a "분기보고서" for the period January 1 – March 31 2026, and it contains detailed financial statements, business overviews, production figures, and management discussion for the quarter. This matches the definition of a comprehensive Interim/Quarterly Report rather than a simple announcement. Therefore, it should be classified as an Interim / Quarterly Report (IR). Q1 2026
2026-05-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 90% confidence The document is titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” a regulatory filing detailing the holdings and changes in holdings of specific securities by an executive (임원) and major shareholder. It itemizes share counts, percentages, and transaction details for a director. This matches the definition of a director’s dealings (insider share transactions) report. Therefore, it is classified as DIRS (Director’s Dealing).
2026-05-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 90% confidence The document is a statutory report filed by an executive (representative director 강석진) disclosing his personal holdings and changes in specific securities of Woojin B&G. It details his share ownership amounts, percentages, and the transactions leading to changes. This matches the definition of an insider transaction report by company directors/executives, corresponding to Director's Dealing (DIRS).
2026-05-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a mandatory report by an executive (“임원ㆍ주요주주 특정증권등 소유상황보고서”) disclosing the insider’s holdings and changes in specific securities. It lists the director’s name, relationship, share quantities, dates, and details of transactions. This matches the criteria for a Director’s Dealing filing (insider share transaction report).
2026-05-11 Korean
소속부변경
Regulatory Filings
2026-04-30 Korean
주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)
Regulatory Filings Classification · 85% confidence The document is a formal announcement of a stock trading suspension (“주권매매거래정지”) due to share consolidation, citing KOSDAQ market rules, with effective dates. It is not a full report, earnings disclosure, or delisting notice, but a routine regulatory exchange filing. Therefore this is best classified as a general Regulatory Filing.
2026-04-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.